PIK3CA and ductal breast carcinoma in situ: Although the majority of samples with a PIK3CA mutation were ER+, there was no significant interaction effect between ER status and the absence or presence of the two types of tested PIK3CA mutations (p = 0.46 for DCIS and p = 0.20 for IBC).